Pharmaceuticals
News Releases
2017
December
Pharmaceuticals
Otsuka to Invest in Megakaryon Corporation, with the Aim to Advance Commercialization of iPS-cell-derived Platelet Preparations
Pharmaceuticals
Otsuka and X-Chem Enter into a Drug Discovery Research and License Collaboration (PDF: 119.0 KB)
Nutraceuticals
Otsuka Pharmaceutical Establishes Joint Research Chair for Women's Health Promotion with Hirosaki University Graduate School of Medicine
Pharmaceuticals
Otsuka Pharmaceutical Co., Ltd. Receives the Japan Medical R&D Grand Prize for Development of Delamanid, a Drug for Multidrug-resistant Tuberculosis Japanese Government Grants Award for the First Time
Corporate
Otsuka Pharmaceutical Unveils It's Completely New Website
Corporate
Otsuka Pharmaceutical Receives Newly Established "Sports Yell Company" Certification from Japan Sports Agency
Nutraceuticals
Observational study of 88 female Kindai University athletes Relationship between premenstrual syndrome-induced interference in athletic performance and equol production status
November
Pharmaceuticals
Otsuka Pharmaceutical to Launch New, Pre-mixed Flavor Formulations (Fruit and Coffee) for Aminoleban EN, an Oral Nutritional Supplement for Patients with Liver Failure
Pharmaceuticals
Otsuka Pharmaceutical Launches New Formulations in Japan of L-Cartin® for Carnitine Deficiencies
Nutraceuticals
Otsuka Pharmaceutical Enters Into Comprehensive Regional Revitalization Partnership Agreement with Yamaguchi Prefecture
Corporate
Otsuka Pharmaceutical Cooperates with Community Health Promotion EffortsTokushima Itano Factory Sponsors "Asan Walking Festa in Itano"
Nutraceuticals
Otsuka Pharmaceutical to Become a Sponsor of the 18th Asian Games
Pharmaceuticals
Otsuka and Proteus Announce the First U.S. FDA Approval of a Digital Medicine System: ABILIFY MYCITE® (aripiprazole tablets with sensor)
Pharmaceuticals
U.S. FDA Accepts Otsuka's Resubmission to Support a Regulatory Review of Tolvaptan in the Treatment of ADPKD
Nutraceuticals
Otsuka Pharmaceutical Enters into Comprehensive Cooperative Partnership with Oita Prefecture
Pharmaceuticals
Otsuka Announces Phase 3 Results for Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Corporate
Otsuka Pharmaceutical Tokushima Wajiki Factory Receives2017 Minister of Economy, Trade and Industry Award for Excellent Greening, a First for the Shikoku Region
Pharmaceuticals
Otsuka and Lundbeck will Initiate a Third Phase 3 Trial to Evaluate Brexpiprazole in the Treatment of Agitation in Patients with Dementia of the Alzheimer's Type
October
Nutraceuticals
US Launch of EQUELLE, a Dietary Supplement to Support Women's Health
Nutraceuticals
Heat Disorders Prevention - Communication Project "Hitosuzumi Awards 2017"Otsuka Pharmaceutical Recognized with "Team Excellence" and "Top Runner" Awards
Pharmaceuticals
Otsuka Submits a Japan NDA for Nalmefene, a Drug to Reduce Alcohol Consumption in Alcohol-Dependent Patients
Pharmaceuticals
Otsuka and Lundbeck Announce Initiation of Two Phase 3 Trials of Brexpiprazole in Patients with Bipolar I Disorder
Nutraceuticals
Otsuka Pharmaceutical Enters into Comprehensive Partnership with Kochi Prefecture
September
August
Pharmaceuticals
Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (DeltybaTM) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries (PDF: 467.1 KB)
Nutraceuticals
Extremely Fine-textured Foam Facial Cleanser Introducing UL·OS Face Wash for Skin Care Evolution of Face Wash from "Cleansing" to "Skin Care"
Corporate
Otsuka Pharmaceutical Participates in Summer Events in Tokushima Exciting Summer in WAJIKI, Tokushima Awa Odori, Oronamin C Drink Presents Awa Odori Sound Festival
July
Pharmaceuticals
ABILIFY MAINTENA® (aripiprazole) for Extended-Release Injectable Suspension Approved by U.S. FDA for Maintenance Monotherapy Treatment of Bipolar I Disorder
Pharmaceuticals
Otsuka Submits New Drug Application in Japan for Aripiprazole Sertraline Combination Tablets
Nutraceuticals
Otsuka Pharmaceutical to Acquire Daiya, a Rapidly Growing Plant-Based Food Company in North America
Nutraceuticals
Otsuka Pharmaceutical Serves as Special Sponsor of Summer Inter-High School Athletic Meeting for Fourth Consecutive Year Event Venue Enlivened with Heat Stroke Prevention Posters and Banners Submitted by Local High School Students
Pharmaceuticals
"Quick Navi-Flu2" Influenza Diagnostic Kit to Launch in Japan
Nutraceuticals
Otsuka Pharmaceutical Enters into Partnership Agreement with Wakayama Prefecture
Nutraceuticals
Otsuka Pharmaceutical Establishes New Functional Food and Beverage Affiliate in Thailand
Pharmaceuticals
Otsuka and R-Pharm Announce Licensing Agreement to Commercialize DeltybaTM (Delamanid) for Multidrug-Resistant Tuberculosis (MDR-TB) in Russia and CIS Countries (PDF: 99.9 KB)
Pharmaceuticals
Smart Medicine Container for Anti-stroke Medicine Approved for Sale in Japan
June
Pharmaceuticals
Quick NaviTM-Mycoplasma Diagnostic Kit to Launch in Japan
Pharmaceuticals
Nalmefene, a Drug Candidate to Reduce Alcohol Consumption, Shows Positive Results from Phase III Trial in Japan
Pharmaceuticals
Otsuka to Continue Commitment to Support the Global Health Innovative Technology Fund (GHIT Fund)
May
Pharmaceuticals
Additional Formulation of Samsca® Granules 1% Available in Japan
Nutraceuticals
Kenja-no-Kaimin Sleep Rhythm Support Asparagus-derived ingredient improves sleep-wake rhythms and enhances quality of sleep
Pharmaceuticals
Otsuka and Proteus Digital Heath Resubmit Application to US FDA for First Digital Medicine
Pharmaceuticals
Otsuka Announces Results of Phase 3 Data on Tolvaptan Under Development for ADPKD in U.S.
Corporate
Otsuka Pharmaceutical Announces Construction of New Pharmaceutical Manufacturing Facility, Tokushima Mima Factory
Corporate
Otsuka Agree to Purchase New Share Allocation of TWO CELLS
Pharmaceuticals
Otsuka and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine Drug Candidate Fremanezumab (TEV-48125)
Corporate
Nutrition & Santé Inaugurates New Gluten-Free Manufacturing Facility
Pharmaceuticals
Otsuka and Lundbeck Announce Results of Brexpiprazole on Symptoms of Agitation Related to Alzheimer's-type Dementia
April
Pharmaceuticals
Otsuka and Akebia Concludes Licensing Agreement for Akebia's Renal Anemia Drug Vadadustat - Development and marketing territories include Europe, China, etc. -
Nutraceuticals
Renewal of Fibe-Mini Dietary Fiber Beverage Food for Specified Health Uses Now Contains Lycopene - Renewal Launch with New Package and Logo Design -
Nutraceuticals
Amino-Value 4000 and Amino-Value Powder 8000 Renewed as Foods with Function Claim "Alleviates Fatigue Caused by Physical Activity"
Nutraceuticals
Otsuka Pharmaceutical Introduces New BODYMAINTÉ Brand BODYMAINTÉ Jelly, a conditioning food to be launched in April 2017
March
Nutraceuticals
Otsuka Pharmaceutical Enters into Health-related Partnership with Fukui Prefecture
Nutraceuticals
Otsuka Pharmaceutical Enters into Comprehensive Partnership Agreement with Ibaraki Prefecture
Pharmaceuticals
Lundbeck and Otsuka's Brexpiprazole for Adult Patients with Schizophrenia Accepted for Review by EMA
Pharmaceuticals
Ribociclib (LEE011) Receives Regulatory Approval in U.S. as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer with an aromatase inhibitor
Pharmaceuticals
Approval for the Additional Formulation of Samsca® Granules 1% in Japan
Corporate
Otsuka Pharmaceutical Appoints Board Members and Statutory Auditors (PDF: 56.1 KB)
Pharmaceuticals
Otsuka Supports "Light-Up in Green" Glaucoma Awareness Activities
Pharmaceuticals
Otsuka Pharmaceutical to Acquire Neurovance, Inc. Acquisition of clinical-stage company in ADHD widens Otsuka's presence in mental health
February
Nutraceuticals
New Addition to Gerblé Line of Nutritional Food Products from Southern France - Prune & Fig Biscuits -
Nutraceuticals
Otsuka Pharmaceutical Enters into Comprehensive Cooperative Agreement with Tochigi Prefecture
Corporate
Otsuka Pharmaceutical Certified as Excellent Health and Productivity Management Enterprise
Nutraceuticals
Otsuka Pharmaceutical Introduces New BODYMAINTÉ Brand BODYMAINTÉ Jelly, a conditioning food to support athletic performance to be launched in April 2017
Nutraceuticals
Otsuka Launches OATHAS Training Program for Healthy Aging Supporters Program to support pharmacies as health information bases with strong connections to local community
Pharmaceuticals
Health Canada Approves Otsuka and Lundbeck's REXULTI (brexpiprazole) as a Treatment for Schizophrenia in Adults
Nutraceuticals
Otsuka Pharmaceutical Supports Tokyo Marathon 2017 as Official Partner Providing comprehensive support for runners' conditioning for the 11th consecutive year
Pharmaceuticals
Osaka University and Otsuka Agree Comprehensive Collaboration : Joint Research Project with Immunology Frontier Research Center (IFReC) (PDF: 226.3 KB)
Nutraceuticals
Otsuka Pharmaceutical Enters into Comprehensive Partnership with Okinawa Prefecture
Nutraceuticals
Otsuka Pharmaceutical Enters into Comprehensive Health-related Agreement with Aichi Prefecture
Nutraceuticals
Otsuka Pharmaceutical Enters into Health Promotion and Disaster Relief Supply Agreements with Kagawa Prefecture
Nutraceuticals
Introducing New SOYJOY Crispy White Macadamia Crunchy soy nutrition bar flavored with soy-based white chocolate and macadamia nuts
January
Nutraceuticals
Otsuka Pharmaceutical Enters into Health Promotion Partnership with Chiba Prefecture
Nutraceuticals
Blocks both Ultraviolet and Near Infrared Radiation Announcing New InnerSignal UV+IR Protect Makeup Base
Pharmaceuticals
Otsuka Files a Supplemental Application in Japan: A Plastic Case with Anti-Stroke Medicine for a Smart Medicine Container
Nutraceuticals
Hokkaido University and Otsuka Pharmaceutical to Collaborate in Joint Research (PDF: 213.0 KB)
Nutraceuticals
Otsuka Pharmaceutical Enters Into Health Promotion Partnership with Shimane Prefecture
Pharmaceuticals
Otsuka Launches a New Treatment for Glaucoma and Ocular Hypertension - Mikeluna® Combination Ophthalmic Solution in Japan
Pharmaceuticals